Evidence map›Paper›PMID 30863790›Full record

ArticleeNeuro

A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation.

Katherine E Savell, Svitlana V Bach, Morgan E Zipperly, Jasmin S Revanna, Nicholas A Goska, Jennifer J Tuscher, Corey G Duke, Faraz A Sultan, Julia N Burke, Derek Williams and 2 more

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Neuro-Cancer Interactions Shape Glioma Intratumoral Heterogeneity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systems.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Katherine E SavellDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.
Svitlana V BachDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.
Morgan E ZipperlyDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.
Jasmin S RevannaDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.
Nicholas A GoskaDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.
Jennifer J TuscherDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.
Corey G DukeDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.ORCID 0000-0003-1102-9549
Faraz A SultanDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.
Julia N BurkeDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.
Derek WilliamsDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.
Lara IanovCivitan International Research Center, University of Alabama at Birmingham, Birmingham, AL, 35294.
Jeremy J DayDepartment of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, 35294.ORCID 0000-0002-7361-3399
University of Alabama at Birmingham · USCivitan International · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008361 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YACOUBIAN, TALENE ALENE · 1992 to 2024
$16.8M
Epigenetic Control of Brain Reward SystemsDP1DA039650 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAY, JEREMY J · 2015 to 2019
$2.3M
Enhancer RNA Regulation of Experience-dependent Neuroepigenetic ProcessesR01MH114990 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAY, JEREMY J · 2018 to 2022
$2.3M
Epigenetic Regulation of Cocaine-Induced NeuroadaptationsR00DA034681 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAY, JEREMY J · 2014 to 2016
$741k
CRISPR/dCas9-Targeted Manipulation of Bdnf Transcription in Synaptic Plasticity and Contextual LearningF32MH112304 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BACH, SVITLANA · 2016 to 2018
$174k
Striatal Modulation of Epigenetic DNA Demethylation in Reward LearningF32DA041778 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SULTAN, FARAZ ALI · 2016 to 2017
$116k
Gene-Specific Epigenetic Modifications in Cocaine-Induced PlasticityF31DA042514 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAVELL, KATHERINE ELIZABETH · 2017 to 2019
$94k
NIDA NIH HHS DP1 DA039650NIDA NIH HHS F31 DA042514NIDA NIH HHS F32 DA041778NIDA NIH HHS R00 DA034681NIGMS NIH HHS T32 GM008361NIMH NIH HHS F32 MH112304NIMH NIH HHS R01 MH114990
6 · The paper itself

Abstract

CRISPR-based technology has provided new avenues to interrogate gene function, but difficulties in transgene expression in post-mitotic neurons has delayed incorporation of these tools in the central nervous system (CNS). Here, we demonstrate a highly efficient, neuron-optimized dual lentiviral CRISPR-based transcriptional activation (CRISPRa) system capable of robust, modular, and tunable gene induction and multiplexed gene regulation across several primary rodent neuron culture systems. CRISPRa targeting unique promoters in the complex multi-transcript gene brain-derived neurotrophic factor (

Indexed as

CRISPR-Cas SystemsGene Expression RegulationGenetic TechniquesAnimalsBrainBrain-Derived Neurotrophic FactorCell Adhesion Molecules, NeuronalCell Line, TumorExtracellular Matrix ProteinsMaleNerve Tissue ProteinsNeuronsPrimary Cell CultureRandom AllocationRats, Sprague-DawleyReelin ProteinBdnf protein, ratBrain-Derived Neurotrophic FactorCell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsNerve Tissue ProteinsReelin ProteinSerine EndopeptidasesBdnfCRISPRepigeneticsgene expressiontranscription

Identifiers

PMID30863790
PMCPMC6412672
OpenAlexW2951366009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.